EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Metronidazole—An Old Drug for Structure Optimization and Repurposing

Vasanti Suvarna, Manikanta Murahari iD, Shrutee Pawar

Chemistry & Biodiversity · 07.06.2025

DOI: 10.1002/cbdv.202403389 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Chemistry & Biodiversity, online erschienen am 07.06.2025. Verfasst von Vasanti Suvarna und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Quality Assurance, SVKM's Dr. Bhanuben Nanavati College of Pharmacy, Mumbai, Maharashtra, India. Hauptthemen laut MEDLINE: Metronidazole, Drug Repositioning, Anti-Infective Agents, Anti-Bacterial Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 193 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metronidazole, a prodrug derived from the nitroimidazole class, continues to serve as a key antimicrobial agent for managing infections caused by anaerobic bacteria, microaerophilic organisms, and protozoan parasites. Its therapeutic activity is primarily exerted under low‐oxygen conditions, wherein the nitro functional group undergoes enzymatic reduction, leading to the cleavage of the imidazole ring and the generation of cytotoxic intermediates. Despite its effectiveness, the increasing prevalence of antimicrobial resistance has prompted the design of new metronidazole analogs, including ruthenium‐based compounds and Schiff base derivatives. These next‐generation agents exhibit broader antimicrobial coverage, alternative mechanisms of action, reduced cytotoxicity, improved efficacy against resistant strains, and potential applications beyond traditional infectious disease contexts. This review provides an in‐depth analysis of metronidazole's clinical relevance, emphasizing the relationship between metabolite structure and cytotoxic effects in both human and rodent models. Additionally, it highlights recent advances in the synthesis of metronidazole derivatives and evaluates their comparative therapeutic benefits relative to the original compound.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetronidazoleDrug RepositioningAnti-Infective AgentsAnti-Bacterial AgentsHumansAnimalsMolecular StructureStructure-Activity RelationshipBacteria

Stichwörter der Autor:innen

anticancerdrug resistancemetronidazole analogsnitroimidazolestructure–activity relationship

Substanzen

MetronidazoleAnti-Infective AgentsAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Quality Assurance, SVKM's Dr. Bhanuben Nanavati College of Pharmacy, Mumbai, Maharashtra, India.
  • K L College of Pharmacy, Koneru Lakshmaiah Education Foundation, Vaddeswaram, Andhra Pradesh, India.

ORCID-Profile: Manikanta Murahari

Zitieren

APA

Suvarna, V., Murahari, M., & Pawar, S. (2025). Metronidazole—An Old Drug for Structure Optimization and Repurposing. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202403389

Vancouver

Suvarna V, Murahari M, Pawar S. Metronidazole—An Old Drug for Structure Optimization and Repurposing. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202403389

BibTeX
@article{Suvarna2025,
  author = {Suvarna, Vasanti and Murahari, Manikanta and Pawar, Shrutee},
  title = {Metronidazole—An Old Drug for Structure Optimization and Repurposing},
  journal = {Chemistry & Biodiversity},
  year = {2025},
  doi = {10.1002/cbdv.202403389}
}
Kostenlos starten →